RxDoctor Payments Data

Alicia Ellsberry

Nurse Practitioner · Gulfport, MSNPI 1497374490

Payments from drug & device makers

$336in general payments, 2019–2025

Across 21 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$124
  • UCB, Inc.$48
  • Johnson & Johnson$44
  • Avanir Pharmaceuticals, Inc.$28
  • Advanced Respiratory, Inc$27
  • Neurocrine Biosciences, Inc.$23
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$336100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$336 in reported general payments places this provider in the 55th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$44,453
Medicare patients
104
Services billed
517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XcopriCenobamate20$21,748
MounjaroTirzepatide13$14,381
BriviactBrivaracetam17$11,962
EliquisApixaban30$9,319
RexultiBrexpiprazole14$7,501
JardianceEmpagliflozin24$7,208
JanuviaSitagliptin Phosphate25$6,980
LinzessLinaclotide11$6,388
FarxigaDapagliflozin Propanediol18$5,264
Meropenem14$2,488
Dronabinol24$2,343
Lacosamide29$2,099
Clobazam20$1,571
Buspirone Hcl35$1,412
Potassium Chloride77$1,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Briviact$48$11,96217 claims
PfizerEliquis$124$9,31930 claims
Boehringer IngelheimJardiance$16$7,20824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →